ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,555 | -74.4% | 1,157 | -64.4% | 0.00% | -66.7% |
| Q2 2023 | $84,331 | +401476.2% | 3,246 | +350.8% | 0.00% | +200.0% |
| Q1 2023 | $21 | -83.6% | 720 | -83.2% | 0.00% | -80.0% |
| Q4 2022 | $128 | -99.7% | 4,295 | +168.3% | 0.01% | +400.0% |
| Q3 2022 | $38,000 | +72.7% | 1,601 | +61.2% | 0.00% | – |
| Q2 2022 | $22,000 | -56.9% | 993 | -51.7% | 0.00% | – |
| Q1 2022 | $51,000 | -5.6% | 2,056 | +36.4% | 0.00% | -100.0% |
| Q4 2021 | $54,000 | +8.0% | 1,507 | +27.0% | 0.00% | 0.0% |
| Q3 2021 | $50,000 | +56.2% | 1,187 | +60.2% | 0.00% | 0.0% |
| Q2 2021 | $32,000 | +52.4% | 741 | +39.8% | 0.00% | – |
| Q1 2021 | $21,000 | +16.7% | 530 | +30.5% | 0.00% | -100.0% |
| Q4 2020 | $18,000 | 0.0% | 406 | -21.3% | 0.00% | – |
| Q3 2020 | $18,000 | -76.6% | 516 | -74.7% | 0.00% | -100.0% |
| Q2 2020 | $77,000 | +208.0% | 2,040 | +320.6% | 0.00% | +50.0% |
| Q4 2019 | $25,000 | +127.3% | 485 | +140.1% | 0.00% | +100.0% |
| Q3 2019 | $11,000 | +57.1% | 202 | -1.0% | 0.00% | 0.0% |
| Q4 2018 | $7,000 | -94.0% | 204 | -94.4% | 0.00% | -83.3% |
| Q2 2018 | $116,000 | +866.7% | 3,626 | +1548.2% | 0.01% | +200.0% |
| Q4 2017 | $12,000 | -90.5% | 220 | -89.8% | 0.00% | -80.0% |
| Q3 2017 | $126,000 | +250.0% | 2,165 | +220.7% | 0.01% | +233.3% |
| Q2 2016 | $36,000 | +800.0% | 675 | +575.0% | 0.00% | +200.0% |
| Q1 2016 | $4,000 | -82.6% | 100 | -83.6% | 0.00% | -75.0% |
| Q4 2015 | $23,000 | -32.4% | 610 | -40.5% | 0.00% | +33.3% |
| Q2 2015 | $34,000 | +78.9% | 1,026 | +126.0% | 0.00% | +50.0% |
| Q1 2015 | $19,000 | +46.2% | 454 | +40.6% | 0.00% | +100.0% |
| Q4 2014 | $13,000 | +550.0% | 323 | +456.9% | 0.00% | – |
| Q3 2014 | $2,000 | -84.6% | 58 | -79.1% | 0.00% | -100.0% |
| Q2 2014 | $13,000 | -60.6% | 277 | -65.4% | 0.00% | -50.0% |
| Q1 2014 | $33,000 | +13.8% | 801 | +4.6% | 0.00% | -20.0% |
| Q4 2013 | $29,000 | -54.0% | 766 | -70.6% | 0.01% | -28.6% |
| Q3 2013 | $63,000 | +2000.0% | 2,602 | +1395.4% | 0.01% | – |
| Q2 2013 | $3,000 | – | 174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |